Khosrow Kashfi,  PhD, FRSC, FRSB
Khosrow Kashfi, PhD, FRSC, FRSB
City University of New York School of Medicine
Verified email at - Homepage
Cited by
Cited by
The dual role of iNOS in cancer
F Vannini, K Kashfi, N Nath
Redox biology 6, 334-343, 2015
Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras
K Kashfi, KR Olson
Biochemical pharmacology 85 (5), 689-703, 2013
A practical guide for induction of type-2 diabetes in rat: Incorporating a high-fat diet and streptozotocin
S Gheibi, K Kashfi, A Ghasemi
Biomedicine & pharmacotherapy 95, 605-613, 2017
Nitric-oxide-donating NSAIDs as agents for cancer prevention
B Rigas, K Kashfi
Trends in molecular medicine 10 (7), 324-330, 2004
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect
K Kashfi, Y Rayyan, LL Qiao, JL Williams, J Chen, P Del Soldato, ...
Journal of Pharmacology and Experimental Therapeutics 303 (3), 1273-1282, 2002
NOSH-Aspirin: A novel nitric oxide–hydrogen sulfide-releasing hybrid: A new class of anti-inflammatory pharmaceuticals
R Kodela, M Chattopadhyay, K Kashfi
ACS medicinal chemistry letters 3 (3), 257-262, 2012
Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association
N Nath, K Kashfi, J Chen, B Rigas
Proceedings of the National Academy of Sciences 100 (22), 12584-12589, 2003
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells
C Bortuzzo, R Hanif, K Kashfi, L Staiano-Coico, SJ Shiff, B Rigas
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1300 (3 …, 1996
Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and β-catenin/T-cell factor signaling, nuclear …
JL Williams, N Nath, J Chen, TR Hundley, J Gao, L Kopelovich, K Kashfi, ...
Cancer research 63 (22), 7613-7618, 2003
NOSH–aspirin (NBS-1120), a novel nitric oxide-and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model
M Chattopadhyay, R Kodela, KR Olson, K Kashfi
Biochemical and biophysical research communications 419 (3), 523-528, 2012
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect
M Chattopadhyay, R Kodela, N Nath, YM Dastagirzada, ...
Biochemical pharmacology 83 (6), 715-722, 2012
Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention
K Kashfi, B Rigas
Biochemical pharmacology 70 (7), 969-986, 2005
Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I
EA Park, RL Mynatt, GA Cook, K Kashfi
Biochemical Journal 310 (3), 853-858, 1995
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) mice
JL Williams, K Kashfi, N Ouyang, P del Soldato, L Kopelovich, B Rigas
Biochemical and biophysical research communications 313 (3), 784-788, 2004
Nitric oxide–donating aspirin prevents pancreatic cancer in a hamster tumor model
N Ouyang, JL Williams, GJ Tsioulias, J Gao, MJ Iatropoulos, L Kopelovich, ...
Cancer research 66 (8), 4503-4511, 2006
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?
RK Yeh, J Chen, JL Williams, M Baluch, TR Hundley, RE Rosenbaum, ...
Biochemical pharmacology 67 (12), 2197-2205, 2004
Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo
M Chattopadhyay, R Kodela, N Nath, A Barsegian, D Boring, K Kashfi
Biochemical pharmacology 83 (6), 723-732, 2012
Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo
K Kashfi, S Borgo, JL Williams, J Chen, J Gao, A Glekas, F Benedini, ...
Journal of Pharmacology and Experimental Therapeutics 312 (3), 978-988, 2005
Anti-inflammatory agents as cancer therapeutics
K Kashfi
Advances in pharmacology 57, 31-89, 2009
Anti-cancer activity of new designer hydrogen sulfide-donating hybrids
K Kashfi
Antioxidants & redox signaling 20 (5), 831-846, 2014
The system can't perform the operation now. Try again later.
Articles 1–20